ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic Interactions.

Area of Science:

• Genomics
• Cancer Biology
• Bioinformatics

Background:

• Synthetic lethal (SL) interactions, where losing either gene is viable but losing both is lethal, offer potential for targeted cancer therapies.
• Identifying clinically relevant SL pairs remains a significant challenge in oncology.
• Current methods struggle to effectively leverage complex genomic and transcriptomic data for SL discovery.

Purpose of the Study:

• To introduce ASTER, a novel statistical hypothesis testing framework for identifying synthetic lethal gene pairs.
• To demonstrate the efficacy of ASTER in utilizing gene expression data to detect SL interactions.
• To develop ASTER++, an extension for large-scale hypothesis testing incorporating additional gene features.

Main Methods:

• ASTER employs statistical hypothesis testing on unified gene expression data from disease-free and cancerous samples.
• The method analyzes patterns of mutual exclusivity in genomic and transcriptomic data as a signal for synthetic lethality.
• ASTER++ extends the framework to handle multiple hypothesis testing and integrate diverse gene features.

Main Results:

• ASTER effectively identifies patterns of mutual exclusivity indicative of synthetic lethality.
• Computational and functional experiments validate ASTER's capability in discovering SL pairs.
• The identified SL pairs show potential for targeted anticancer therapeutic strategies.

Conclusions:

• ASTER provides a robust computational approach for discovering synthetic lethal interactions.
• The method leverages gene expression data to uncover therapeutically relevant gene pairs.
• ASTER and ASTER++ represent significant advancements in the search for novel cancer treatments.